Seelos Therapeutics, Inc. Common Stock
SEEL
SEEL was delisted on the 15th of October, 2024.
2 hedge funds and large institutions have $9.4M invested in Seelos Therapeutics, Inc. Common Stock in 2015 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
260% more call options, than puts
Call options by funds: $108K | Put options by funds: $30K
33% less funds holding
Funds holding: 3 → 2 (-1)
35% less capital invested
Capital invested by funds: $14.5M → $9.4M (-$5.09M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HVC
Healthcare Value Capital
Woodcliff Lake,
New Jersey
|
-$1.43M |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$18K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Morgan Stanley
New York
| $9K | – | – | – |
|
|
AIG
27
American International Group
New York
| $6K | – | – | – |
|
28
BlackRock
New York
| $3K | – | – | – |
|
29
UBS Group
Zurich,
Switzerland
| $2K | – | – | – |
|
30
Citigroup
New York
| $1K | – | – | – |
|
|
HDIM
31
Hanson & Doremus Investment Management
Burlington,
Vermont
| $1K | – | – | – |
|
|
ST
32
Sphinx Trading
Chicago,
Illinois
| $1K | – | – | – |
|
33
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $4 | – | – | – |
|
|
SM
34
Sabby Management
Miami Beach,
Florida
| – | -$18K | – | – |
|
SEEL Hedge Fund Activity: Q4 2015 in Review
2 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Seelos Therapeutics, Inc. Common Stock (SEEL) for Q4 2015, worth a combined $9.4M — down 35% from $14.5M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of SEEL and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Healthcare Value Capital, exiting entirely with an estimated $1.43M sold.
- 2 institutional investors held Seelos Therapeutics, Inc. Common Stock (SEEL) as of Q4 2015, down from 3 in Q3 2015.
- Funds reported $9.4M of Seelos Therapeutics, Inc. Common Stock stock for Q4 2015, down 35% quarter-over-quarter.
- 0 funds opened new Seelos Therapeutics, Inc. Common Stock positions in Q4 2015 and 1 closed out, a net change of -1 holder.
- The largest Seelos Therapeutics, Inc. Common Stock seller in Q4 2015 was Healthcare Value Capital, an estimated $1.43M sold.
Based on aggregated 13F filings for Q4 2015.